{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:03:55Z","timestamp":1780106635941,"version":"3.54.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf - Case Rep"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40800-017-0057-9","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T19:10:14Z","timestamp":1508785814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quetiapine-Induced Hypomania and its Association with Quetiapine\/Norquetiapine Plasma Concentrations: A Case Series of Bipolar Type 2 Patients"],"prefix":"10.1007","volume":"4","author":[{"given":"C.","family":"Rovera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ciappolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Buoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"57_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241\u201351.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"57_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/08039488.2014.990919","volume":"69","author":"AC Altamura","year":"2015","unstructured":"Altamura AC, Serati M, Buoli M. Is duration of illness really influencing outcome in major psychoses? Nord J Psychiatry. 2015;69(6):403\u201317.","journal-title":"Nord J Psychiatry"},{"key":"57_CR3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/11207280-000000000-00000","volume":"25","author":"M Sanford","year":"2011","unstructured":"Sanford M. Quetiapine extended release: adjunctive treatment in major depressive disorder. CNS Drugs. 2011;25:803\u201313.","journal-title":"CNS Drugs"},{"key":"57_CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jad.2013.08.024","volume":"152\u2013154","author":"M Buoli","year":"2014","unstructured":"Buoli M, Serati M, Altamura AC. Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. J Affect Disord. 2014;152\u2013154:12\u20138.","journal-title":"J Affect Disord"},{"key":"57_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","volume":"10","author":"H Grunze","year":"2009","unstructured":"Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10:85\u2013116.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"57_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","volume":"11","author":"H Grunze","year":"2010","unstructured":"Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81\u2013109.","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"57_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/bdi.12038","volume":"15","author":"LN Yatham","year":"2013","unstructured":"Yatham LN, Kennedy SH, Parikh SV, et al. The evolution of CANMAT bipolar disorder guidelines: past, present, and future. Bipolar Disord. 2013;15(1):58\u201360.","journal-title":"Bipolar Disord"},{"issue":"6","key":"57_CR8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/acps.12343","volume":"130","author":"DM Taylor","year":"2014","unstructured":"Taylor DM, Cornelius V, Smith L, Young AH. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatr Scand. 2014;130(6):452\u201369.","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"57_CR9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4088\/JCP.v65n1116","volume":"65","author":"F Rachid","year":"2004","unstructured":"Rachid F, Bertschy G, Bondolfi G, Aubry JM. Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. J Clin Psychiatry. 2004;65(11):1537\u201345.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"57_CR10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/157488612803251333","volume":"7","author":"RB Khalil","year":"2012","unstructured":"Khalil RB, Baddoura C. Quetiapine induced hypomania: a case report and a review of the literature. Curr Drug Saf. 2012;7(3):250\u20133.","journal-title":"Curr Drug Saf"},{"issue":"11","key":"57_CR11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","volume":"170","author":"I Pacchiarotti","year":"2013","unstructured":"Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249\u201362.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"57_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","volume":"30","author":"GM Goodwin","year":"2016","unstructured":"Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendation from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30(6):495\u2013553.","journal-title":"J Psychopharmacol"},{"key":"57_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eurpsy.2015.12.004","volume":"33","author":"V Osborne","year":"2016","unstructured":"Osborne V, Davies M, Layton D, Shakir SA. Utilisation of extended release quetiapine (Seroquel XL\u2122): results from an observational cohort study in England. Eur Psychiatry. 2016;33:61\u20137.","journal-title":"Eur Psychiatry"},{"key":"57_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fpsyt.2012.00082","volume":"3","author":"PH Silverstone","year":"2012","unstructured":"Silverstone PH, Lalies MD, Hudson AL. Quetiapine and buspirone both elevate cortical levels of noradrenaline and dopamine in vivo, but do not have synergistic effects. Front Psychiatry. 2012;3:82.","journal-title":"Front Psychiatry"},{"key":"57_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/nedt.2006.2.2.139","volume":"2","author":"E Mundo","year":"2006","unstructured":"Mundo E, Cattaneo E, Zanoni S, et al. The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder. Neuropsychiatr Dis Treat. 2006;2:139\u201348.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/JCP.0b013e318287acc9","volume":"33","author":"H Rasmussen","year":"2013","unstructured":"Rasmussen H, Ebdrup BH, Aggernaes B, et al. Norquetiapine and depressive symptoms in initially antipsychotic-naive first-episode schizophrenia. J Clin Psychopharmacol. 2013;33:266\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"57_CR17","first-page":"281","volume":"10","author":"A S\u00fcmegi","year":"2008","unstructured":"S\u00fcmegi A. Quetiapine in bipolar disorders. Neuropsychopharmacol Hung. 2008;10:281\u201391.","journal-title":"Neuropsychopharmacol Hung"},{"key":"57_CR18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.euroneuro.2012.05.012","volume":"23","author":"C Bj\u00f6rkholm","year":"2013","unstructured":"Bj\u00f6rkholm C, Jardemark K, Marcus MM, et al. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine. Eur Neuropsychopharmacol. 2013;23:709\u201320.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"57_CR19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11597330-000000000-00000","volume":"32","author":"AC Altamura","year":"2012","unstructured":"Altamura AC, Moliterno D, Paletta S, et al. Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study. Clin Drug Investig. 2012;32(3):213\u20139.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"57_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/FTD.0000000000000413","volume":"39","author":"C Rovera","year":"2017","unstructured":"Rovera C, Mauri MC, Di Pace C, et al. Effect of N-desalkylquetiapine\/quetiapine plasma level ratio on anxiety and depression in bipolar disorder: a prospective observational study. Ther Drug Monit. 2017;39(4):441\u20135.","journal-title":"Ther Drug Monit"},{"key":"57_CR21","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders, Fifth Revision","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Fifth Revision. Washington, DC: American Psychiatric Press; 2013."},{"issue":"5","key":"57_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40262-013-0127-9","volume":"53","author":"Q Li","year":"2014","unstructured":"Li Q, Su YA, Liu Y, Chen JX, et al. Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia. Clin Pharmacokinet. 2014;53(5):455\u201365.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"57_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4088\/JCP.08m04854yel","volume":"71","author":"SL McElroy","year":"2010","unstructured":"McElroy SL, Martens BE, Creech RS, et al. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania. J Clin Psychiatry. 2010;71(5):557\u201365.","journal-title":"J Clin Psychiatry"},{"key":"57_CR24","doi-asserted-by":"publisher","unstructured":"Buoli M, Esposito CM, Godio M, Caldiroli A, Serati M, Altamura AC. Have antipsychotics a different speed of action in the acute treatment of mania? A single-blind comparative study. J Psychopharmacol. 2017:269881117705098. doi: 10.1177\/0269881117705098 (Epub ahead of print).","DOI":"10.1177\/0269881117705098"},{"issue":"2","key":"57_CR25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","volume":"47","author":"V Selle","year":"2014","unstructured":"Selle V, Schalkwijk S, V\u00e1zquez GH, Baldessarini RJ. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry. 2014;47(2):43\u201352.","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"57_CR26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/acps.12753","volume":"136","author":"M Have Ten","year":"2017","unstructured":"Ten Have M, Penninx BWJH, Tuithof M, et al. Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population. Acta Psychiatr Scand. 2017;136(3):300\u201312.","journal-title":"Acta Psychiatr Scand"},{"key":"57_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.08.059","author":"M Buoli","year":"2017","unstructured":"Buoli M, Serati M, Altamura AC. Biological aspects and candidate biomarkers for rapid-cycling in bipolar disorder: a systematic review. Psychiatry Res. 2017. doi: 10.1016\/j.psychres.2017.08.059 (Epub ahead of print).","journal-title":"Psychiatry Res."},{"key":"57_CR28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2318-9-5","volume":"9","author":"HJ Hamilton","year":"2009","unstructured":"Hamilton HJ, Gallagher PF, O\u2019Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9:5.","journal-title":"BMC Geriatr"},{"issue":"7","key":"57_CR29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/0269881110389208","volume":"25","author":"G Nikisch","year":"2011","unstructured":"Nikisch G, Baumann P, Oneda B, et al. Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia: a pilot study. J Psychopharmacol. 2011;25(7):896\u2013907.","journal-title":"J Psychopharmacol"},{"key":"57_CR30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jad.2016.10.010","volume":"208","author":"M Buoli","year":"2017","unstructured":"Buoli M, Dell\u2019Osso B, Caldiroli A, et al. Obesity and obstetric complications are associated with rapid-cycling in Italian patients with bipolar disorder. J Affect Disord. 2017;208:278\u201383.","journal-title":"J Affect Disord"}],"container-title":["Drug Safety - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40800-017-0057-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0057-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0057-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T21:45:54Z","timestamp":1570225554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40800-017-0057-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s40800-017-0057-9","relation":{},"ISSN":["2199-1162","2198-977X"],"issn-type":[{"value":"2199-1162","type":"print"},{"value":"2198-977X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"article-number":"13"}}